Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rapid Responses to:
|
|
Rapid Responses published:
|
|
|||
|
Claus Dr. Koehnlein, Medical Doctor int.med. 24103 Kiel Germany, Königsweg 14
Send response to journal:
|
The observation of Harris et al.(BMJ2002;324:450,23 Febr.)are well in line with those made by Thomas et al.(JAMA,July 26,2000-Vol284,No4) and Seef et al.(Ann Int.Med.2000;123:105-111). They all found low liver related morbidity and mortality rates, exept in people who drink excessive alcohol. We dont need a virus to explain this. Going back to the roots of Hepatitis C we find in The Lancet,Saturday 4 March 1978,Alter et al,that there was no transmissable agent found. Instead blood from a patient with non-A,non-B Hepatitis was inoculated into five chimps. Three of the animals developed a transient elevation of aminotransferases around week 15. A control animal was kept in a seperate room. The possibility of immunreactions against foreign blood was not ruled out. The control should have had five chimps inoculated with blood of a healthy donor. At one of the last Hepatitis C meetings in Paris M.Hougthon one of the codiscoverers of the sequences we call now Hepatitis C virus asked into the audience: who has ever seen the hepatitis C-virus? Answer: nobody did. My question : how do we know that a high viral load which we are measuring with PCR is indeed infectious virus? There is no paper showing a correlation with free infectious virus particles( visible with Electronmicroskopy)and a high "viral load". Are we facing a PCR-Artefact? I am afraid we do. According to George Venters who published recently in your journal(BMJ,Vol323,13 oct,2001)I would like to make the following points: 1.The causal link between the HCV and livercirrhosis is open to question.
In view of this observations of the above named authors which corresponds to my own and many of my collegues it seems problematic to treat healthy HCV-Pos.patients on the basis of a high "viral load" with interferon and ribavirin. |
|||